Bioengineered microbes as a platform for discovering chemical rescuers of diseas...
Bioengineered microbes as a platform for discovering chemical rescuers of disease-related misfolding of integral membrane proteins
Protein misfolding diseases (PMDs) are a large group of human disorders caused by the misfolding of specific proteins. They include conditions with high socio-economic impact, such as Alzheimer’s disease, cystic fibrosis, obesity...
Protein misfolding diseases (PMDs) are a large group of human disorders caused by the misfolding of specific proteins. They include conditions with high socio-economic impact, such as Alzheimer’s disease, cystic fibrosis, obesity and type 2 diabetes, and the majority of them remain incurable. Among the >70 PMDs, about 1/3 are caused by misfolding-prone membrane proteins (MisMPs). Despite their significance, and mainly due to the difficulties associated with MisMP overexpression, isolation and characterization, the PMD scientific community has largely overlooked MisMP-associated PMDs, thus limiting opportunities for drug discovery. In ProMisMe, we will develop engineered bacteria and yeast, which can function as broadly applicable discovery platforms for compounds that rescue MisMP misfolding. These compounds will be selected from libraries of drug-like molecules biosynthesized in these microbes using a technology that allows the facile production of tens of millions to tens of billions of different test molecules. These libraries will then be screened in the same microbial cells that produce them and the rare molecules that rescue MisMP misfolding effectively will be selected by ultrahigh-throughput screening. The effect of the selected molecules on MisMP folding will then evaluated by biochemical and biophysical methods, while their ability to reverse MisMP-induced pathogenicity will be tested in appropriate mammalian cell assays. The molecules that rescue the misfolding and associated pathogenicity of the target MisMPs will become therapeutic candidates against the corresponding diseases. This procedure will be applied for different MisMPs to identify potential therapeutics for two serious PMDs: Usher Syndrome III and Charcot-Marie-Tooth disease. Successful realization of ProMisMe will provide invaluable therapeutic leads against major diseases and a more widely applicable framework for drug discovery against diseases caused by membrane protein misfolding.ver más
06-11-2024:
IDAE Cadena de Valor...
Se ha cerrado la línea de ayuda pública: Ayudas a Proyectos para reforzar la Cadena de Valor de equipos necesarios para la transición a una economía de cero emisiones netas
05-11-2024:
Cataluña Gestión For...
Se abre la línea de ayuda pública: Gestión Forestal Sostenible para Inversiones Forestales Productivas para el organismo:
04-11-2024:
Doctorados industria...
Se ha cerrado la línea de ayuda pública: Formación de doctores y doctoras de las universidades del Sistema universitario de Galicia (SUG) en empresas y centros de innovación y tecnología para el organismo:
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.